170382 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Lectins
ASSAYS FOR ANTIMICROBIAL ACTIVITY AND APPLICATIONS THEREOF
#2Methods for Standardizing Lectin Reagents, IgA1 Calibration Standards, and Quantitative Measurement of Galactose-Deficient IgA1 in Human Samples
#3METHODS FOR DETECTION OF PROSTATE CANCER, RELATED BIOMARKERS AND KITS FOR DETERMINING THE BIOMARKERS
#4BIOMARKERS
#5ANTI-BDCA2 ANTIBODY AND USE THEREOF
#6METHODS AND KITS FOR QUANTIFYING GLYCOSYLATED ANALYTES
#7MEANS AND METHODS FOR HIGH-THROUGHPUT GLYCOPROFILING OF PROTEINS
#8RAPID MULTIPLEXED ANALYSIS OF RELEASED GLYCANS BY DUAL-STAGE MICROFLUIDIC CAPTURE AND PARALLEL FLUORESCENT TAGGING PRIOR TO LC ANALYSIS
#9A METHOD FOR DIAGNOSIS OF TRAUMATIC BRAIN INJURY
#10MONITORING INFLAMMATION STATUS
#11METHOD OF DETECTING TISSUE DAMAGE
#12HIGHLY SENSITIVE IMMUNOASSAY REAGENT AND MEASUREMENT METHOD
#13LECTIN-BASED DIAGNOSTICS OF CANCERS
#14SYSTEM COMPRISING ARTIFICIAL INTELLIGENCE INTEGRATED MOLECULAR CYTOLOGY AND RADIOLOGY FOR TRIAGING OF THYROID NODULES
#15DEVICES AND METHODS FOR TREATING A VIRAL INFECTION AND SYMPTOMS THEREOF
#16USE OF LECTINS TO DETERMINE MAMMAGLOBIN-A GLYCOFORMS IN BREAST CANCER
#17ENGINEERED MICROBE-TARGETING MOLECULES AND USES THEREOF
#18ANTI-GALECTIN-9 ANTIBODIES AND USES THEREOF IN THE TREATMENT OF OCULAR MELANOMA
#19ORTHOGONALLY REDUNDANT SENSOR SYSTEMS AND METHODS
#20GAL3BP POLYPEPTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER AND DETERMINING TREATMENT RESPONSIVENESS
#21GALECTIN-3 IMMUNOASSAY
#22ASSAYS FOR RAPID DETECTION OF AIRBORNE VIRUSES INCLUDING INFLUENZA AND CORONAVIRUSES
#23METHOD OF MEASURING COMPLEX CARBOHYDRATES
#24NOVEL CANCER BIOMARKER IN PANCREATIC CANCER OR MALIGNANT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM
#25PEPTIDE DESIGN AND GALECTIN-3 INHIBITORS
#26Method And System For Determining Intracellular Mediators' Activity
#27METHODS AND COMPOSITIONS FOR DETECTING VIRUSES
#28SAMPLE PREPARATION AND MICROBIAL ANALYSIS
#29MAGNETIC ANALYSIS OF EXTRACELLULAR VESICLE GLYCANS
#30Lectin-binding substance measurement method, lectin-binding substance measurement kit, and blocked labeled lectin for use in these
#31REAGENT FOR DETECTING TARGET SUBSTANCE CONTAINING SUGAR CHAIN, DETECTION METHOD, CARRIER USED IN DETECTION OF TARGET SUBSTANCE CONTAINING SUGAR CHAIN, AND METHOD FOR MANUFACTURING SAID CARRIER
#32CANCER TEST METHOD
#33ANTI-GALECTIN-9 ANTIBODIES AND USES THEREOF
#34METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#35Multivalent glycan microarray platform
#36Orthogonally redundant sensor systems and methods
#37DETECTING ELEMENTS USING SUGAR-LECTIN COUPLINGS
#38ASSAYS FOR ANTIMICROBIAL ACTIVITY AND APPLICATIONS THEREOF
#39Calibrator, complex, and method for measuring IgA aggregate
#40METHOD AND KIT FOR DETERMINING POSSIBILITY OF ONSET OF IGA NEPHROPATHY
#41METHODS FOR CAPTURING, ISOLATION, AND TARGETING OF CIRCULATING TUMOR CELLS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF
#42Galectin-10 antibodies
#43Lectin-based diagnostics of cancers
#44DIAGNOSTIC METHOD(S) FOR DETECTING AND TREATING POST-INFARCT MYOCARDIUM REMODELING AND DIFFUSE MYOCARDIAL FIBROSIS
#45IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#46METHOD AND KIT FOR THE DIAGNOSIS OF COLORECTAL CANCER
#47METHOD FOR DETECTING BACTERIA ACCORDING TO THE GRAM SIGNAL THEREOF IN A COMPLEX SAMPLE
#48Engineered microbe-targeting molecules and uses thereof
#49Kit for tracking and diagnosing degree of progressive chronic hepatitis and liver fibrosis by measuring asialo (alpha)1-acid glycoprotein as hepatocellular injury marker and use thereof
#50Assays for antimicrobial activity and applications thereof
#51REG3A AND REG FAMILY MEMBER BIOMARKERS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CANCER
#52Engineered microbe-targeting molecules and uses thereof
#53Methods for detecting sinusoidal obstructive syndrome (SOS)
#54BRAIN SPECIFIC EXOSOME BASED DIAGNOSTICS AND EXTRACORPOREAL THERAPIES
#55METHODS AND COMPOSITIONS FOR QUANTIFYING EXOSOMES
#56Methods and kits for exosome isolation and quantification
#57Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#58GALECTIN-3 IMMUNOASSAY
#59Method for estimating Gleason score of prostate cancer, method for estimating pathological stage, and method for acquiring supplementary information, all on the basis of specific PSA content in specimen
#60IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#61Galectin-10 antibodies
#62COMPOSITIONS, KITS, AND METHODS FOR THE DIAGNOSIS, PROGNOSIS, AND MONITORING OF IMMUNE DISORDERS USING GALECTIN-1
#63Methods for capturing, isolation, and targeting of circulating tumor cells and diagnostic and therapeutic applications thereof
#64Multivalent glycan microarray platform
#65Orthogonally redundant sensor systems and methods
#66Antibodies and related molecules and uses thereof
#67PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#68Method, biomarker and diagnostic agent for detection of high-risk prostate cancer
#69Method and kit for the diagnosis of colorectal cancer
#70Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
#71Determination of glycosylation signature
#72Method for isolating cancer stem cells
#73Method for Detecting Cancer Stem Cells
#74Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#75Compositions and methods relating to galectin detection
#76GENOTOXICITY ASSAY WITH CYTOPLASM BOUNDARY LABELING
#77METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE
#78Biomarker for detecting cancer
#79GALECTIN-3 IMMUNOASSAY
#80Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#81Method and Kit for Determining Risk of Preterm Birth and/or Birth of Low-Birth-Weight Baby
#82Engineered microbe-targeting molecules and uses thereof
#83Assays for antimicrobial activity and applications thereof
#84IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#85COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
#86ANNEXIN A2 AS IMMUNOLOGICAL TARGET
#87METHODS FOR DIAGNOSING, PROGNOSING AND TREATING MUSCULAR DYSTROPHY
#88Orthogonally redundant sensor systems and methods
#89CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY
#90Lymphangiogenesis inhibitors for cancer and for graft survival
#91Agents and methods for determining colorectal cancer status
#92Probiotic function of human intelectin
#93Sandwich assay using labeled lectin and kit therefor
#94Method and Compositions for the Diagnosis of a Thyroid Condition
#95Lectins and applications for the detection of pathological state markers
#96GALECTIN-9-SECRETING CELL, AND PRODUCTION METHOD AND USE OF THE SAME
#97Reagent for detecting target substance containing sugar chain, detection method, carrier used in detection of target substance containing sugar chain, and method for manufacturing said carrier
#98Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#99Galectin-3 as immunological target
#100Container
#101Assays for antimicrobial activity and applications thereof
#102Assays for screening for or identifying an agent or molecule that can block or inhibit AVB3 integrin from forming a complex with KRAS
#103Method for analyzing PSA, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA
#104Method of traceless labeling glycoproteins on surface and application thereof
#105Methods for diagnosis and treatment of concussion or brain injury
#106Galactoside inhibitor of galectins
#107Methods and compositions for detecting non-hematopoietic cells from a blood sample
#108Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition
#109Methods and Compositions for the Diagnosis of a Thyroid Condition
#110METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#111GALECTIN-3 AS A MARKER FOR PROSTATE CANCER
#112Compositions and methods for detecting plectin-1 as a biomarker for cancer
#113MDL-1 ligand
#114Immunoassay method less affected by impurities
#115Glycoform detection method and glycoform detection device
#116Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
#117Compounds and Methods for Modulating an Immune Response
#118Immunomodulating compositions and uses therefor
#119TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#120Undifferentiated cell detection method and complex carbohydrate detection method
#121Methods for diagnosing, prognosing and treating muscular dystrophy
#122CARIES RISK TEST FOR PREDICTING AND ASSESSING THE RISK OF DISEASE
#123Method for increasing the proportion of animal cells secreting galectin-9
#124Methods and compositions for separating rare cells from fluid samples
#125METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#126Biomarker for detecting cancer
#127Methods for identifying inhibitors of mannan-binding lectin-associated serine protease (MASP) proteins and uses thereof
#128Binding-site modified lectins and uses thereof
#129Methods of determining efficacy of treatment in a subject having heart failure
#130Engineered microbe-targeting molecules and uses thereof
#131Annexin A2 as immunological target
#132Fucoidans as ligands for the diagnosis of degenerative pathologies
#133Galactoside inhibitor of galectins
#134Methods and compositions for detecting non-hematopoietic cells from a blood sample
#135Microorganism detection and analysis using carbohydrate and lectin recognition
#136Dendritic cell marker and uses thereof
#137Polysaccharide and derivatives thereof, showing affinity to ficolin-3, method of preparation and use
#138Systems and methods for medical data processing and analysis
#139Quantum dot-based optical sensors for rapid detection and quantitative analysis of biomolecules and biological materials
#140Methods for detecting graft-versus-host disease
#141COLORECTAL CANCER MARKER GALECTIN, METHOD FOR ANALYZING GALECTIN CONCENTRATION IN BLOOD SAMPLE, AND KIT FOR DETECTING COLORECTAL CANCER MARKER GALECTIN
#142Methods for treating muscular dystrophy
#143OPTICAL SENSING SYSTEMS AND METHODS
#144Orthogonally redundant sensor systems and methods
#145INHIBITORS OF GALECTIN-3 AND METHODS OF USE THEREOF
#146Methods for Diagnosing The Malignant Potential of Pancreatic Cystic Lesions
#147Method of diagnosing renal dysfunction in a cat based on non-cauxin protein levels
#148RAPID DETECTION OF CEREBROSPINAL FLUID, METHODS AND SYSTEMS THEREFORE
#149Method for analyzing PSA, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA
#150Methods predicting risk of an adverse clinical outcome
#151CARIES RISK TEST FOR PREDICTING AND ASSESSING THE RISK OF DISEASE
#152Cancer diagnosis marker using the aberrant glycosylation of a protein
#153Methods for identifying inhibitors of mannan-binding lectin associated serine protease (MASP) proteins and uses thereof
#154USE OF GALECTIN-3 FOR DETECTING AND PROGNOSING HEART FAILURE AFTER ACUTE CORONARY SYNDROME
#155METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#156Compositions and methods for detecting plectin-1 as a biomarker for cancer
#157Device for securing the edge of a floor covering to a profile construction
#158Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies
#159Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease
#160Method and Assay for Glycosylation Pattern Detection Related to Cell State
#161Methods for differentiating plasma-derived protein from recombinant protein in a sample
#162Compounds and Methods for Modulating an Immune Response
#163GALECTIN-3 AND STATIN THERAPY
#164METHOD FOR DIAGNOSING ENDOMETRIAL CANCER
#165Method for analyzing PSA and method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA
#166ANNEXIN A2 AS IMMUNOLOGICAL TARGET
#167METHODS AND COMPOSITIONS FOR THE REGULATION OF LECTIN COMPLEMENT PATHWAY (LCP)-ASSOCIATED COMPLEMENT ACTIVATION IN HYPERGLYCEMIC MYOCARDIAL DAMAGE
#168BINDING-SITE MODIFIED LECTINS AND USES THEREOF
#169MODULATORS OF MONOGLYCERIDE LIPASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#170Method for screening cancer therapeutic agent using galectin-3, GSK-3β, and fascin-1
#171CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY
#172Methods of identifying tumor associated glycoproteins
#173L-fucose α1→6 specific lectin
#174DETECTION OF PROSTATE CANCER USING PSA GLYCOSYLATION PATTERNS
#175Dendritic cell marker and uses thereof
#176Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#177Methods of identifying anti-inflammatory compounds
#178Galectin-3 and cardiac resynchronization therapy
#179ASSESSING CONGESTIVE HEART RISK IN PATIENTS TREATED OR POTENTIALLY TO BE TREATED WITH A PEROXISOME-PROLIFERATOR-ACTIVATOR-RECEPTOR-GAMMA AGONIST OR A THIAZOLIDINEDIONE
#180RAPID LATERAL FLOW GLYCAN-DETECTING DEVICE
#181Method for predicting the risk of disease based on lectin binding
#182NOVEL PROTEINS WITH TARGETED BINDING
#183Lectin-based glycan assay
#184Protein scaffolds and uses thereof
#185Diagnostic kit for detecting urinary protein of a cat after cauxin removal
#186Galectin-3 Immunoassay
#187Isoform specificities of blood serum proteins and their use as differentially expressed protein biomarkers for diagnosis of breast cancer
#188METHODS FOR SCREENING FOR THERAPEUTIC MOLECULES AND USE OF THE MOLECULES THEREFROM
#189MUC1 and galectin-3
#190Identities, specificities, and use of twenty two (22) differentially expressed protein biomarkers for blood based diagnosis of breast cancer
#191Lectin complement pathway assays and related compositions and methods
#192Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
#193Methods of identifying anti-inflammatory compounds
#194Methods for differentiating plasma-derived protein from recombinant protein in a sample
#195Use of the ENDO-180 gene and polypeptide for diagnosis and treatment
#196Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1
#197Multi-lectin affinity chromatography and uses thereof
#198METHODS AND COMPOSITIONS FOR THE IDENTIFICATION OF CANCER MARKERS
#199Method for the diagnosis of rheumatoid arthritis
#200High Affinity Nucleic Acid Ligands To Lectins
#201METHOD OF DETECTING SUGAR CHAINS HAVING GlcNAc TRANSFERRED BY GnT-V
#202Method of producing blood type checking reagent containing lectin
#203Reagents and methods to enrich rare cells from body fluids
#204Twelve (12) protein biomarkers for diagnosis and early detection of breast cancer
#205Predicting agent for metastasis
#206METHOD FOR TAILORING ADMINISTRATION OF DRUGS BY QUANTITATION OF MRNA
#207Methods for characterizing glycosylation sites
#208COMPOSITIONS AND METHODS FOR REGULATING RECEPTOR CLUSTERING
#209Method of microorganism detection using carbohydrate and lectin recognition
#210Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
#211Blood type checking reagent containing lectin
#212Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of Diseases
#213TUMOR ASSOCIATION OF MDL-1 AND METHODS
#214Device and Method for Protein Analysis
#215Methods for Detecting L-Ficolin Dependent Activation of the Lectin Pathway of Complement and Kits Therefor
#216Immunomodulating compositions and uses therefor
#217Methods and compositions for separating rare cells from fluid samples
#218Galectins -1 and -4 in tumor development
#219Use of the endo-180 gene and polypeptide for diagnosis and treatment
#220Lectin binding to choroidal neovascularization
#221Caries risk test for predicting and assessing the risk of disease
#222Serum biomarkers in ischaemic heart disease
#223Methods and compositions for detecting non-hematopoietic cells from a blood sample
#224Method and assay for early diagnosis of prostate cancer
#225Protein scaffolds and uses thereof
#226Method for determining the glucose concentration by fluorescence polarization
#227Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
#228Method for detecting a lectin-like substance
#229Tumor association of MDL-1 and methods
#230Lectin for checking blood type, blood type checking reagent containing the lectin, and method of checking blood type using the blood type checking reagent
#231Methods for increasing production of IFN-gamma in natural killer cells expressing LLT1 receptor
#232Novel proteins with targeted binding
#233Method for selectively separating blood cells by using lectin